SEC Form 4 · accession 0001638599-16-000967
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur J Roth
Director
Period of report
May 31, 2016
Accepted (ET)
Jun 1, 2016 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 31, 2016 | M | 5,000 | $10.37 | A | 47,349 | D | |
| Common Stock | May 31, 2016 | F | 3,576 | $14.50 | D | 43,773 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2 | $10.37 | May 31, 2016 | M | 5,000 | A | — | Jun 1, 2016 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1Consists of shares withheld to pay exercise price.
- F2Option grant was fully exercisable on June 1, 2007